{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:24:38Z","timestamp":1791498278079,"version":"4.3.4"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T00:00:00Z","timestamp":1715817600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","thrombosisresearch.com","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.thromres.2024.109037","type":"journal-article","created":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T09:52:34Z","timestamp":1715939554000},"page":"109037","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Risk of recurrent venous thromboembolism and bleeding in patients with acute isolated subsegmental pulmonary embolism"],"prefix":"10.1016","volume":"239","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-1350-4783","authenticated-orcid":false,"given":"Laura","family":"Girardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo Augusto","family":"Ciuffini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicky","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Santagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Ageno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Fei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Carrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gr\u00e9goire","family":"Le Gal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2024.109037_bb0005","doi-asserted-by":"crossref","unstructured":"R. C. Auer et al., \u201cUse of helical CT is associated with an increased incidence of postoperative pulmonary emboli in cancer patients with no change in the number of fatal pulmonary emboli,\u201d J. Am. Coll. Surg., vol. 208, no. 5, pp. 871\u2013878, May 2009, doi:https:\/\/doi.org\/10.1016\/J.JAMCOLLSURG.2008.12.030.","DOI":"10.1016\/j.jamcollsurg.2008.12.030"},{"key":"10.1016\/j.thromres.2024.109037_bb0010","doi-asserted-by":"crossref","unstructured":"G. Le Gal et al., \u201cRisk for recurrent venous thromboembolism in patients with subsegmental pulmonary embolism managed without anticoagulation: a multicenter prospective cohort study,\u201d Ann. Intern. Med., vol. 175, no. 1, pp. 29\u201335, Jan. 2022, doi:https:\/\/doi.org\/10.7326\/M21-2981.","DOI":"10.7326\/L22-0038"},{"key":"10.1016\/j.thromres.2024.109037_bb0015","doi-asserted-by":"crossref","unstructured":"A. Bariteau, L. K. Stewart, T. W. Emmett, and J. A. Kline, \u201cSystematic review and Meta-analysis of outcomes of patients with subsegmental pulmonary embolism with and without anticoagulation treatment,\u201d Acad. Emerg. Med., vol. 25, no. 7, pp. 828\u2013835, Jul. 2018, doi:https:\/\/doi.org\/10.1111\/ACEM.13399.","DOI":"10.1111\/acem.13399"},{"key":"10.1016\/j.thromres.2024.109037_bb0020","doi-asserted-by":"crossref","unstructured":"S. M. Stevens et al., \u201cExecutive summary: antithrombotic therapy for VTE disease: second update of the CHEST guideline and expert panel report,\u201d Chest, vol. 160, no. 6, pp. 2247\u20132259, Dec. 2021, doi:https:\/\/doi.org\/10.1016\/J.CHEST.2021.07.056.","DOI":"10.1016\/j.chest.2021.07.056"},{"key":"10.1016\/j.thromres.2024.109037_bb0025","doi-asserted-by":"crossref","unstructured":"S. Schulman and C. Kearon, \u201cDefinition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients,\u201d J. Thromb. Haemost., vol. 3, no. 4, pp. 692\u2013694, Apr. 2005, doi:https:\/\/doi.org\/10.1111\/J.1538-7836.2005.01204.X.","DOI":"10.1111\/j.1538-7836.2005.01204.x"},{"key":"10.1016\/j.thromres.2024.109037_bb0030","doi-asserted-by":"crossref","unstructured":"S. Kaatz, D. Ahmad, A. C. Spyropoulos, and S. Schulman, \u201cDefinition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH,\u201d J. Thromb. Haemost., vol. 13, no. 11, pp. 2119\u20132126, Nov. 2015, doi:https:\/\/doi.org\/10.1111\/JTH.13140.","DOI":"10.1111\/jth.13140"},{"key":"10.1016\/j.thromres.2024.109037_bb0035","doi-asserted-by":"crossref","unstructured":"P. Prandoni et al., \u201cRecurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis,\u201d Blood, vol. 100, no. 10, pp. 3484\u20133488, Nov. 2002, doi:https:\/\/doi.org\/10.1182\/BLOOD-2002-01-0108.","DOI":"10.1182\/blood-2002-01-0108"},{"key":"10.1016\/j.thromres.2024.109037_bb0040","doi-asserted-by":"crossref","unstructured":"A. T. Cohen, A. Katholing, S. Rietbrock, L. Bamber, and C. Martinez, \u201cEpidemiology of first and recurrent venous thromboembolism in patients with active cancer. A population-based cohort study,\u201d Thromb. Haemost., vol. 117, no. 1, pp. 57\u201365, Jan. 2017, doi:https:\/\/doi.org\/10.1160\/TH15-08-0686.","DOI":"10.1160\/TH15-08-0686"},{"key":"10.1016\/j.thromres.2024.109037_bb0045","doi-asserted-by":"crossref","unstructured":"M. Yan, R. Kieser, C. C. Wu, W. Qiao, and C. M. Rojas-Hernandez, \u201cClinical factors and outcomes of subsegmental pulmonary embolism in cancer patients,\u201d Blood Adv., vol. 5, no. 4, pp. 1050\u20131058, Feb. 2021, doi:https:\/\/doi.org\/10.1182\/BLOODADVANCES.2020003136.","DOI":"10.1182\/bloodadvances.2020003136"},{"key":"10.1016\/j.thromres.2024.109037_bb0050","doi-asserted-by":"crossref","unstructured":"N. Kraaijpoel et al., \u201cTreatment and long-term clinical outcomes of incidental pulmonary embolism in patients with Cancer: an international prospective cohort study,\u201d J. Clin. Oncol., vol. 37, no. 20, pp. 1713\u20131720, Jul. 2019, doi:https:\/\/doi.org\/10.1200\/JCO.18.01977.","DOI":"10.1200\/JCO.18.01977"},{"key":"10.1016\/j.thromres.2024.109037_bb0055","doi-asserted-by":"crossref","unstructured":"H. Robert-Ebadi and M. Righini, \u201cThe 2019 ESC guidelines on pulmonary embolism: some further insights,\u201d Eur. J. Intern. Med., vol. 77, pp. 6\u20138, Jul. 2020, doi:https:\/\/doi.org\/10.1016\/J.EJIM.2020.05.007.","DOI":"10.1016\/j.ejim.2020.05.007"},{"key":"10.1016\/j.thromres.2024.109037_bb0060","doi-asserted-by":"crossref","unstructured":"N. S. Key et al., \u201cVenous thromboembolism prophylaxis and treatment in patients with Cancer: ASCO clinical practice guideline update,\u201d J. Clin. Oncol., vol. 38, no. 5, pp. 496\u2013520, Feb. 2020, doi:https:\/\/doi.org\/10.1200\/JCO.19.01461.","DOI":"10.1200\/JCO.19.01461"},{"key":"10.1016\/j.thromres.2024.109037_bb0065","doi-asserted-by":"crossref","unstructured":"G. H. Lyman et al., \u201cAmerican Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer,\u201d Blood Adv., vol. 5, no. 4, pp. 927\u2013974, Feb. 2021, doi:https:\/\/doi.org\/10.1182\/BLOODADVANCES.2020003442.","DOI":"10.1182\/bloodadvances.2021004734"},{"key":"10.1016\/j.thromres.2024.109037_bb0070","doi-asserted-by":"crossref","unstructured":"D. Farge et al., \u201c2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19,\u201d Lancet Oncol., vol. 23, no. 7, pp. e334\u2013e347, Jul. 2022, doi:https:\/\/doi.org\/10.1016\/S1470-2045(22)00160-7.","DOI":"10.1016\/S1470-2045(22)00160-7"},{"key":"10.1016\/j.thromres.2024.109037_bb0075","doi-asserted-by":"crossref","unstructured":"P. Wiklund, K. Medson, and J. Elf, \u201cUnreported incidental pulmonary embolism in patients with cancer: radiologic natural history and risk of recurrent venous thromboembolism and death,\u201d Thromb. Res., vol. 224, pp. 65\u201372, Apr. 2023, doi:https:\/\/doi.org\/10.1016\/J.THROMRES.2023.02.010.","DOI":"10.1016\/j.thromres.2023.02.010"},{"key":"10.1016\/j.thromres.2024.109037_bb0080","doi-asserted-by":"crossref","unstructured":"C. Kearon et al., \u201cAntithrombotic therapy for VTE disease: CHEST guideline and expert panel report,\u201d Chest, vol. 149, no. 2, pp. 315\u2013352, Feb. 2016, doi:https:\/\/doi.org\/10.1016\/J.CHEST.2015.11.026.","DOI":"10.1016\/j.chest.2015.11.026"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384824001695?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384824001695?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T04:44:26Z","timestamp":1717562666000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384824001695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":16,"alternative-id":["S0049384824001695"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2024.109037","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of recurrent venous thromboembolism and bleeding in patients with acute isolated subsegmental pulmonary embolism","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2024.109037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109037"}}